SS1(dsFv)-PE38

DB17579InvestigationalProtein Based Therapies

SS1(dsFv)-PE38 is a recombinant anti-mesothelin immunotoxin. SS1(dsFv)-PE38 is under investigation in clinical trial NCT01051934 (A Phase I Trial of SS1 (Dsfv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With...

Mechanism: Pharmacologically active on Mesothelin
Curator reviewed
Also known as: SS1(dsFv)-PE38 immunotoxin
Code names: SS1(dsFv)-PE38

Resolves to

Targets

Q13421MSLN

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with SS1(dsFv)-PE38, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account